2023 Q3 Form 10-K Financial Statement

#000117184323005488 Filed on August 30, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2022 Q3 2022
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $418.9K $639.3K $3.540M
YoY Change -34.48% -41.81% -43.63%
% of Gross Profit
Research & Development $172.5K $290.0K $1.087M
YoY Change -40.52% -8.91% -34.37%
% of Gross Profit
Depreciation & Amortization $3.590K $11.15K $30.02K
YoY Change -67.8% 81.3% 8.04%
% of Gross Profit
Operating Expenses $591.4K $929.3K $4.627M
YoY Change -36.36% -34.41% -41.69%
Operating Profit -$4.627M
YoY Change -41.69%
Interest Expense $75.63K $27.21K $45.28K
YoY Change 177.95% 1529.34% 23.14%
% of Operating Profit
Other Income/Expense, Net $0.00 $674.2K -$321.4K
YoY Change -100.0% -1247.99%
Pretax Income -$515.7K -$608.1K -$4.949M
YoY Change -15.19% -57.03% -37.42%
Income Tax
% Of Pretax Income
Net Earnings -$588.3K -$608.1K -$4.949M
YoY Change -3.26% -57.03% -37.42%
Net Earnings / Revenue
Basic Earnings Per Share -$0.09
Diluted Earnings Per Share -$0.01 -$0.01 -$0.09
COMMON SHARES
Basic Shares Outstanding 53.20M shares 53.20M shares 53.20M shares
Diluted Shares Outstanding 53.20M shares

Balance Sheet

Concept 2023 Q3 2022 Q3 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.993M $8.078M $8.078M
YoY Change -25.81% -33.39% -33.39%
Cash & Equivalents $492.6K $8.078M
Short-Term Investments $5.500M $0.00 $0.00
Other Short-Term Assets $311.9K $284.6K $284.6K
YoY Change 9.58% 49.04% 49.04%
Inventory
Prepaid Expenses $24.25K
Receivables
Other Receivables
Total Short-Term Assets $6.304M $8.362M $8.362M
YoY Change -24.61% -32.11% -32.11%
LONG-TERM ASSETS
Property, Plant & Equipment $1.315M $1.330M $1.330M
YoY Change -1.11% -4.13% -4.13%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Assets $1.315M $1.330M $1.330M
YoY Change -1.11% -5.6% -5.6%
TOTAL ASSETS
Total Short-Term Assets $6.304M $8.362M $8.362M
Total Long-Term Assets $1.315M $1.330M $1.330M
Total Assets $7.620M $9.692M $9.692M
YoY Change -21.38% -29.39% -29.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $114.1K $118.4K $118.4K
YoY Change -3.62% 113.68% 113.68%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $287.2K $118.4K $118.4K
YoY Change 142.64% -30.43% -30.43%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $287.2K $118.4K $118.4K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $287.2K $118.4K $118.4K
YoY Change 142.64% -30.43% -30.43%
SHAREHOLDERS EQUITY
Retained Earnings -$75.38M -$72.98M
YoY Change 3.28% 7.27%
Common Stock $53.20K $53.20K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.333M $9.574M $9.574M
YoY Change
Total Liabilities & Shareholders Equity $7.620M $9.692M $9.692M
YoY Change -21.38% -29.39% -29.39%

Cashflow Statement

Concept 2023 Q3 2022 Q3 2022
OPERATING ACTIVITIES
Net Income -$588.3K -$608.1K -$4.949M
YoY Change -3.26% -57.03% -37.42%
Depreciation, Depletion And Amortization $3.590K $11.15K $30.02K
YoY Change -67.8% 81.3% 8.04%
Cash From Operating Activities -$500.7K -$762.0K -$3.641M
YoY Change -34.29% 6.62% 36.91%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$244.6K $357.0K
YoY Change -100.0% 944.53% -567.6%
Acquisitions
YoY Change
Other Investing Activities $500.0K $0.00 $5.000M
YoY Change -200.04%
Cash From Investing Activities $500.0K $244.6K $4.643M
YoY Change 104.39% -1144.53% -191.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -500.7K -762.0K -$3.641M
Cash From Investing Activities 500.0K 244.6K $4.643M
Cash From Financing Activities 0.000
Net Change In Cash -660.0 -517.3K $950.4K
YoY Change -99.87% -29.38% -113.56%
FREE CASH FLOW
Cash From Operating Activities -$500.7K -$762.0K -$3.641M
Capital Expenditures $0.00 -$244.6K $357.0K
Free Cash Flow -$500.7K -$517.3K -$3.998M
YoY Change -3.22% -25.15% 54.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001071840
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
usd
CY2022Q3 us-gaap Deposits Assets
DepositsAssets
usd
CY2022Q3 wndw Related Party Payables
RelatedPartyPayables
usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022 us-gaap Revenues
Revenues
usd
CY2021 us-gaap Revenues
Revenues
usd
CY2021 us-gaap Other Income
OtherIncome
usd
CY2022 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
usd
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
CY2022 wndw Increase Decrease Operating In Lease Assets And Liabilities
IncreaseDecreaseOperatingInLeaseAssetsAndLiabilities
usd
CY2022 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
usd
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
usd
CY2022 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
usd
CY2022Q3 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
usd
CY2021Q3 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-08-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--08-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
333-127953
CY2022 dei Entity Registrant Name
EntityRegistrantName
SOLARWINDOW TECHNOLOGIES, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
59-3509694
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
9375 E. Shea Blvd.
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 107-B
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Scottsdale
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85260
CY2022 dei City Area Code
CityAreaCode
(800)
CY2022 dei Local Phone Number
LocalPhoneNumber
213-0689
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 dei Entity Public Float
EntityPublicFloat
50772000 usd
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
53198399 shares
CY2022 dei Auditor Name
AuditorName
PKF O’Connor Davies, LLP
CY2022 dei Auditor Location
AuditorLocation
New York, New York
CY2022 dei Auditor Firm
AuditorFirmId
127
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8077849 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7127456 usd
CY2021Q3 us-gaap Short Term Investments
ShortTermInvestments
5000000 usd
CY2022Q3 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
153799 usd
CY2021Q3 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
122332 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
130831 usd
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
68649 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
8362479 usd
CY2021Q3 us-gaap Assets Current
AssetsCurrent
12318437 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
110418 usd
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
110271 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1329992 usd
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1387342 usd
CY2021Q3 us-gaap Deposits Assets
DepositsAssets
21598 usd
CY2022Q3 us-gaap Assets
Assets
9692471 usd
CY2021Q3 us-gaap Assets
Assets
13727377 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
118376 usd
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
55402 usd
CY2021Q3 wndw Related Party Payables
RelatedPartyPayables
114750 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
118376 usd
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
170152 usd
CY2022Q3 us-gaap Liabilities
Liabilities
118376 usd
CY2021Q3 us-gaap Liabilities
Liabilities
170152 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53198399 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53198399 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53198399 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53198399 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
53198 usd
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
53198 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
82576002 usd
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
81551840 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-73631 usd
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14872 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-72981474 usd
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-68032941 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
9574095 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
13557225 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9692471 usd
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13727377 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3539824 usd
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6279263 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1087328 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1656634 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
4627152 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
7935897 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-4627152 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-7935897 usd
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
45279 usd
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
36770 usd
CY2022 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
-380220 usd
CY2021 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
-8775 usd
CY2022 us-gaap Other Income
OtherIncome
13560 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-321381 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
27995 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-4948533 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-7907902 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
58759 usd
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
14872 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5007292 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7922774 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53198399 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53198399 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53107648 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53107648 shares
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-15967129 usd
CY2021 wndw Exercise Of Warrants
ExerciseOfWarrants
689472 usd
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
35400 usd
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4787998 usd
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-14872 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-7907902 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
13557225 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1024162 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-58759 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-4948533 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
9574095 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-4948533 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-7907902 usd
CY2022 us-gaap Depreciation
Depreciation
30024 usd
CY2021 us-gaap Depreciation
Depreciation
27794 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
1024162 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
4787998 usd
CY2021 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-8775 usd
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
380220 usd
CY2022 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
31467 usd
CY2021 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-452399 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
46064 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
31453 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
65598 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1938 usd
CY2021 wndw Increase Decrease Operating In Lease Assets And Liabilities
IncreaseDecreaseOperatingInLeaseAssetsAndLiabilities
353 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-114750 usd
CY2021 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
1564 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3640810 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2659240 usd
CY2021 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
5000000 usd
CY2022 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
5000000 usd
CY2022 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
356966 usd
CY2021 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
76338 usd
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2161 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4643034 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5074177 usd
CY2021 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
724872 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
724872 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-51831 usd
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-15522 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
950393 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7024067 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7127456 usd
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14151523 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8077849 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7127456 usd
CY2022 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
380220 usd
CY2022Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
8077849 usd
CY2022Q3 wndw Working Capital
WorkingCapital
8244103 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8077849 usd
CY2022Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
7216466 usd
CY2022Q3 us-gaap Cash
Cash
8077849 usd
CY2021Q3 us-gaap Cash
Cash
7127456 usd
CY2021Q3 us-gaap Short Term Investments
ShortTermInvestments
5000000 usd
CY2022Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
8077849 usd
CY2021Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
12127456 usd
CY2021 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
19281917 shares
CY2022 wndw Total Shares Not Included In Computation Of Diluted Loss Per Share
TotalSharesNotIncludedInComputationOfDilutedLossPerShare
26043317 shares
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-4948533 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-7907902 usd
CY2022 wndw Weighted Average Number Of Common Shares Outstanding
WeightedAverageNumberOfCommonSharesOutstanding
53198399 shares
CY2021 wndw Weighted Average Number Of Common Shares Outstanding
WeightedAverageNumberOfCommonSharesOutstanding
53107648 shares
CY2022 wndw Basic And Diluted Eps Computation
BasicAndDilutedEpsComputation
-0.09
CY2021 wndw Basic And Diluted Eps Computation
BasicAndDilutedEpsComputation
-0.15
CY2022 us-gaap Incremental Common Shares Attributable To Written Put Options
IncrementalCommonSharesAttributableToWrittenPutOptions
6761400 shares
CY2021 us-gaap Incremental Common Shares Attributable To Written Put Options
IncrementalCommonSharesAttributableToWrittenPutOptions
6740400 shares
CY2022 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
19281917 shares
CY2021 wndw Total Shares Not Included In Computation Of Diluted Loss Per Share
TotalSharesNotIncludedInComputationOfDilutedLossPerShare
26022317 shares
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
58759 usd
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
14872 usd
CY2022 wndw Foreign Currency Exchange Rates Translation1
ForeignCurrencyExchangeRatesTranslation1
1,342.00
CY2022 wndw Foreign Currency Translation Weighted Average Exchange Rate
ForeignCurrencyTranslationWeightedAverageExchangeRate
1,230.36
CY2021 wndw Foreign Currency Exchange Rates Translation1
ForeignCurrencyExchangeRatesTranslation1
1,157.50
CY2021 wndw Foreign Currency Translation Weighted Average Exchange Rate
ForeignCurrencyTranslationWeightedAverageExchangeRate
1,128.80
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1440410 usd
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1497613 usd
CY2022 us-gaap Property Plant And Equipment Gross Period Increase Decrease
PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease
54795 usd
CY2022Q3 us-gaap Property Plant And Equipment Other Accumulated Depreciation
PropertyPlantAndEquipmentOtherAccumulatedDepreciation
110418 usd
CY2021Q3 us-gaap Property Plant And Equipment Other Accumulated Depreciation
PropertyPlantAndEquipmentOtherAccumulatedDepreciation
110271 usd
CY2022 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease
-16948 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1329992 usd
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1387342 usd
CY2022 wndw Property Plant And Equipmen Net Period Increase Decrease
PropertyPlantAndEquipmenNetPeriodIncreaseDecrease
37847 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
356966 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
76338 usd
CY2022 us-gaap Depreciation
Depreciation
30024 usd
CY2021 us-gaap Depreciation
Depreciation
27794 usd
CY2022 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
7468 usd
CY2022 us-gaap Payments For Deposits
PaymentsForDeposits
512000 usd
CY2022 us-gaap Proceeds From Refunds From Suppliers Of Material
ProceedsFromRefundsFromSuppliersOfMaterial
186000 usd
CY2019 wndw Estimated Cost
EstimatedCost
1803000 usd
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2161 usd
CY2021 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-8775 usd
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53198399 shares
CY2022Q3 wndw Shares Of Common Stock Issuable From Warrants
SharesOfCommonStockIssuableFromWarrants
19281917 shares
CY2021Q3 wndw Shares Of Common Stock Issuable From Warrants
SharesOfCommonStockIssuableFromWarrants
19281917 shares
CY2022 wndw Options Outstanding
OptionsOutstanding
153000 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
2.60
CY2022 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
939232 usd
CY2021 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
4138160 usd
CY2022 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
84930 usd
CY2021 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
649838 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
1024162 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
4787998 usd
CY2021Q3 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
2325267 usd
CY2022 wndw Rent Description
RentDescription
The apartment lease provided for a term of one year beginning March 7, 2021, monthly rent of approximately $950 and a security deposit of approximately $8,700.
CY2022 us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
The Lease had an initial term of three years through May 1, 2022 with monthly rent due of $2,200 for the first two years and $2,266 during year three.
CY2019Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
418 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
24730 usd
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
53513 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-3755493 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-7317016 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-1193040 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-590886 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4948533 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7907902 usd
CY2022Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
7977402 usd
CY2021Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
7183162 usd
CY2022Q3 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
990618 usd
CY2021Q3 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
1020152 usd
CY2022Q3 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
2508105 usd
CY2022Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
11476125 usd
CY2021Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
10528507 usd
CY2022Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11474539 usd
CY2021Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
10526590 usd
CY2022Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1586 usd
CY2021Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1917 usd
CY2022Q3 wndw Depreciation1
Depreciation1
-1586 usd
CY2021Q3 wndw Depreciation1
Depreciation1
-1917 usd
CY2022Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1586 usd
CY2021Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1917 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
947949 usd
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
567602 usd
CY2022Q3 us-gaap Tax Basis Of Investments Cost For Income Tax Purposes
TaxBasisOfInvestmentsCostForIncomeTaxPurposes
36316546 usd
CY2022Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
1403706 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1039192 usd
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1660659 usd
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
32513 usd
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
23635 usd
CY2022 wndw Permanent Differences
PermanentDifferences
-79846 usd
CY2021 wndw Permanent Differences
PermanentDifferences
115928 usd
CY2022 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
-32236 usd
CY2022 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
-11674 usd
CY2021 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
-16531 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-947949 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1783691 usd
CY2022Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd

Files In Submission

Name View Source Status
0001171843-23-005488-index-headers.html Edgar Link pending
0001171843-23-005488-index.html Edgar Link pending
0001171843-23-005488.txt Edgar Link pending
0001171843-23-005488-xbrl.zip Edgar Link pending
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_321.htm Edgar Link pending
f10k_083023.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
f10k_083023_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wndw-20220831.xsd Edgar Link pending
wndw-20220831_cal.xml Edgar Link unprocessable
wndw-20220831_lab.xml Edgar Link unprocessable
wndw-20220831_pre.xml Edgar Link unprocessable
wndw-20220831_def.xml Edgar Link unprocessable